Tezepelumab Efficacy By SNOT-22 Score In Patients With Severe, Uncontrolled Asthma And Comorbid Nasal Polyps In NAVIGATOR

被引：0

作者：

Jacobs, Joshua ^{[1
]}

Hoyte, Flavia ^{[2
]}

Spahn, Joseph ^{[3
]}

Ambrose, Chris ^{[4
]}

Martin, Nicole ^{[5
,6
]}

Vong, Sylvia ^{[7
]}

Caveney, Scott ^{[8
]}

Cook, Bill ^{[4
]}

Colice, Gene ^{[9
]}

机构：

[1] Allergy & Asthma Clin Res, Walnut Creek, CA USA

[2] Natl Jewish Hlth, Div Allergy & Immunol, Denver, CO USA

[3] AstraZeneca, BioPharmaceut Med, Resp & Immunol, Wilmington, DE USA

[4] AstraZeneca, BioPharmaceut Med, Resp & Immunol, Gaithersburg, MD USA

[5] AstraZeneca, BioPharmaceut R&D, Resp & Immunol, Biometr,Late Stage Dev, Waltham, MA USA

[6] Cytel Inc, Waltham, MA USA

[7] AstraZeneca, BioPharmaceut R&D, Early Resp & Immunol, Translat Sci & Expt Med, Gaithersburg, MD USA

[8] Amgen Inc, R&D, Global Dev, Inflammat, Thousand Oaks, CA 91320 USA

[9] AstraZeneca, Biopharmaceut R&D, Resp & Immunol, Late Stage Dev, Gaithersburg, MD USA

来源：

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

052

引用

页码：AB17 / AB17

页数：1